Similarly, George et al expressed an intracellular domain of Notch2 (N2ICD; an active form of the Notch receptor) in the Rb/p53/Rbl2-mutant cells of a GEMM and found a significant reduction in lung tumor development and the growth inhibition of SCLC cell lines20. Here, RBL2 is linked to small cell lung carcinoma.